GSK First Foreign Pharma To Stop Kickbacks For Drug Sales
This article was originally published in PharmAsia News
GSK is making drastic reforms on its sales practices in China, and announced it would stop paying its sales representatives according to their sales.
You may also be interested in...
Comments ahead of the vaccine advisory committee ranged from public health groups opposed to emergency use authorizations, to industry requests for guidance on EUA labeling materials.
"One of the issues that COVID-19 has brought out is, how safe is the production of animal-based food products?"
Positive clinical results in Parkinson’s pave path forward for Japanese firm’s potential istradefylline successor.